Stock Scorer

Omega Healthcare Investors Inc (OHI)

Omega Healthcare Investors Inc reported revenue of 328.2M USD for the quarter ending 30 June 2026, up 16.2% from 282.5M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 328.2M +16.2%
Operating Income Q2 '26 · ending 30 June 2026 330.9M +124.0%
Net Income Q2 '26 · ending 30 June 2026 362.8M +165.6%
Operating Cash Flow Q2 '26 · ending 30 June 2026 217.7M -9.0%
Shares Outstanding Q2 '26 · ending 30 June 2026 316.2M +7.2%
EPS Q2 '26 · ending 30 June 2026 2.80 +72.8%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1.2B—590.2M—
20242024-12-31 1.1B—406.3M—
20232023-12-31 949.7M—242.2M—
20222022-12-31 878.2M—438.8K—
20212021-12-31 1.1B—428.3K—
20202020-12-31 892.4M—163.5M—
20192019-12-31 928.8M551.7M351.9M—
20182018-12-31 881.7M497.6M293.9M—
20172017-12-31 908.4M315.2M104.9M—
20162016-12-31 900.8M560M383.4M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30328.2M
Q1 '262026-03-31323M
Q4 '252025-12-31319.2M
Q3 '252025-09-30311.6M
Q2 '252025-06-30282.5M
Q1 '252025-03-31276.8M
Q4 '242024-12-31279.3M
Q3 '242024-09-30276M
Q2 '242024-06-30252.7M
Q1 '242024-03-31243.3M
Q4 '232023-12-31239.3M
Q3 '232023-09-30242M
Q2 '232023-06-30250.2M
Q1 '232023-03-31218.2M
Q4 '222022-12-31144.8M
Q3 '222022-09-30239.4M
Q2 '222022-06-30244.6M
Q1 '222022-03-31249.3M
Q4 '212021-12-31249.9M
Q3 '212021-09-30281.7M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30330.9M
Q2 '252025-06-30281.2M
Q3 '202020-09-30-39.5M
Q2 '202020-06-30156.5M
Q1 '202020-03-31147.7M
Q4 '192019-12-31115.9M
Q3 '192019-09-30187.2M
Q2 '192019-06-30126.5M
Q1 '192019-03-31122.2M
Q4 '182018-12-31116.1M
Q3 '182018-09-30110.7M
Q2 '182018-06-30132.7M
Q1 '182018-03-31138.1M
Q4 '172017-12-31123.1M
Q3 '172017-09-30-88.2M
Q2 '172017-06-30141.1M
Q1 '172017-03-31139.2M
Q4 '162016-12-31196.9M
Q3 '162016-09-30124.3M
Q2 '162016-06-30142.2M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30362.8M
Q1 '262026-03-31151M
Q4 '252025-12-31164.8M
Q3 '252025-09-30179.7M
Q2 '252025-06-30136.6M
Q1 '252025-03-31109M
Q4 '242024-12-31113.3M
Q3 '242024-09-30111.8M
Q2 '242024-06-30113.9M
Q1 '242024-03-3167.4M
Q4 '232023-12-3156.5M
Q3 '232023-09-3093.9M
Q2 '232023-06-3061.5M
Q1 '232023-03-3136.8M
Q4 '222022-12-3146.7M
Q3 '222022-09-30105.1M
Q2 '222022-06-3091.9M
Q1 '222022-03-31195.2M
Q4 '212021-12-3134.2M
Q3 '212021-09-30142.8M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30217.7M
Q1 '262026-03-31215.5M
Q4 '252025-12-31230.6M
Q3 '252025-09-30226.7M
Q2 '252025-06-30239.3M
Q1 '252025-03-31182M
Q4 '242024-12-31229M
Q3 '242024-09-30184.9M
Q2 '242024-06-30184.1M
Q1 '242024-03-31151.5M
Q4 '232023-12-31165M
Q3 '232023-09-30171M
Q2 '232023-06-30170.4M
Q1 '232023-03-31111.4M
Q4 '222022-12-31153.7M
Q3 '222022-09-30166.8M
Q2 '222022-06-30173M
Q1 '222022-03-31132.2M
Q4 '212021-12-31156.5M
Q3 '212021-09-30187.3M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-30316.2M
Q1 '262026-03-31315.1M
Q3 '252025-09-30308.2M
Q2 '252025-06-30303.2M
Q1 '252025-03-31294.9M
Q3 '242024-09-30275.6M
Q2 '242024-06-30261.5M
Q1 '242024-03-31257.3M
Q3 '232023-09-30256M
Q2 '232023-06-30246.1M
Q1 '232023-03-31243.2M
Q3 '222022-09-30243.3M
Q2 '222022-06-30243.3M
Q1 '222022-03-31247.6M
Q3 '212021-09-30246.6M
Q2 '212021-06-30243.9M
Q1 '212021-03-31239.9M
Q3 '202020-09-30233.7M
Q2 '202020-06-30234.5M
Q1 '202020-03-31234.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-302.80
Q1 '262026-03-312.07
Q4 '252025-12-311.93
Q3 '252025-09-301.79
Q2 '252025-06-301.62
Q1 '252025-03-311.61
Q4 '242024-12-311.55
Q3 '242024-09-301.36
Q2 '242024-06-301.31
Q1 '242024-03-311.11
Q4 '232023-12-310.99
Q3 '232023-09-300.97
Q2 '232023-06-301.03
Q1 '232023-03-311.16
Q4 '222022-12-311.80
Q3 '222022-09-301.73
Q2 '222022-06-301.88
Q1 '222022-03-311.86
Q4 '212021-12-311.76
Q3 '212021-09-301.91